Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $248.75 | 3 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $125.00 | 1 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $101.94 | 1 | $0 (2023) |
| Edwards Lifesciences Corporation | $21.81 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $101.94 | 1 | AstraZeneca Pharmaceuticals LP ($101.94) |
| 2021 | $125.00 | 1 | Novo Nordisk Inc ($125.00) |
| 2018 | $21.81 | 1 | Edwards Lifesciences Corporation ($21.81) |
All Payment Transactions
3 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/24/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $101.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/11/2021 | Novo Nordisk Inc | RYBELSUS (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Diabetes | ||||||
| 07/12/2018 | Edwards Lifesciences Corporation | ClearSight System (Device) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: Noninvasive Hemodynamic Monitoring | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 589 | 644 | $777,465 | $59,343 |
| 2022 | 5 | 659 | 708 | $798,261 | $63,973 |
| 2021 | 5 | 582 | 618 | $761,898 | $63,107 |
| 2020 | 5 | 498 | 528 | $750,267 | $63,396 |
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 284 | 314 | $541,650 | $41,241 | 7.6% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 128 | 137 | $162,619 | $12,289 | 7.6% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 42 | 43 | $27,950 | $2,344 | 8.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 14 | 14 | $29,386 | $2,256 | 7.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 106 | 121 | $9,680 | $735.60 | 7.6% |
| 99282 | Emergency department visit with straightforward medical decision making | Facility | 2023 | 15 | 15 | $6,180 | $476.55 | 7.7% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 306 | 340 | $583,170 | $46,469 | 8.0% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 87 | 92 | $107,116 | $8,524 | 8.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 25 | 25 | $52,061 | $4,271 | 8.2% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 64 | 65 | $41,034 | $3,558 | 8.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 177 | 186 | $14,880 | $1,151 | 7.7% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 299 | 325 | $556,637 | $46,252 | 8.3% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 73 | 77 | $89,496 | $7,310 | 8.2% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 38 | 38 | $79,078 | $6,488 | 8.2% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 37 | 42 | $25,807 | $2,184 | 8.5% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 135 | 136 | $10,880 | $872.34 | 8.0% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 256 | 277 | $469,805 | $39,435 | 8.4% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 113 | 119 | $135,367 | $11,344 | 8.4% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 49 | 50 | $92,253 | $8,979 | 9.7% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 69 | 71 | $51,962 | $3,563 | 6.9% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 11 | 11 | $880.00 | $73.81 | 8.4% |
About Dr. Jason Ray, MD
Dr. Jason Ray, MD is a Emergency Medicine healthcare provider based in Woodward, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1942395801.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jason Ray, MD has received a total of $248.75 in payments from pharmaceutical and medical device companies, with $101.94 received in 2023. These payments were reported across 3 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($248.75).
As a Medicare-enrolled provider, Ray has provided services to 2,328 Medicare beneficiaries, totaling 2,498 services with total Medicare billing of $249,818. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Location Woodward, OK
- Active Since 10/04/2006
- Last Updated 10/24/2024
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1942395801
Products in Payments
- RYBELSUS (Drug) $125.00
- FARXIGA (Drug) $101.94
- ClearSight System (Device) $21.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.